Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Di...
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
About this item
Full title
Author / Creator
Kovacs, Christopher S., MD , Seshiah, Veeraswamy, MD, FRCP , Merker, Ludwig, MD , Christiansen, Anita Vedel, MSc, Pharm , Roux, Flavien, MSc , Salsali, Afshin, MD , Kim, Gabriel, MD , Stella, Peter, MD , Woerle, Hans-Juergen, MD , Broedl, Uli C., MD , on behalf of the EMPA-REG EXTEND™ PIO investigators and EMPA-REG EXTEND™ PIO investigators
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Abstract Purpose To investigate the long-term efficacy and safety of empagliflozin as add-on therapy to pioglitazone with or without metformin in patients with type 2 diabetes mellitus. Methods Of 498 patients randomized to empagliflozin 10 mg, empagliflozin 25 mg, or placebo once daily for 24 weeks in the EMPA-REG PIO™ study, 305 (61.2%) were trea...
Alternative Titles
Full title
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
Authors, Artists and Contributors
Author / Creator
Seshiah, Veeraswamy, MD, FRCP
Merker, Ludwig, MD
Christiansen, Anita Vedel, MSc, Pharm
Roux, Flavien, MSc
Salsali, Afshin, MD
Kim, Gabriel, MD
Stella, Peter, MD
Woerle, Hans-Juergen, MD
Broedl, Uli C., MD
on behalf of the EMPA-REG EXTEND™ PIO investigators
EMPA-REG EXTEND™ PIO investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1710001681
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1710001681
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2015.05.511
